NASDAQ:ALNY - Alnylam Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$83.12 +2.44 (+3.02 %)
(As of 01/22/2019 07:46 AM ET)
Previous Close$80.68
Today's Range$79.00 - $83.18
52-Week Range$60.27 - $153.99
Volume1.06 million shs
Average Volume883,462 shs
Market Capitalization$8.41 billion
P/E Ratio-15.34
Dividend YieldN/A
Beta2.32

Analyst Ratings

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for Alnylam Pharmaceuticals in the last 12 months. Their average twelve-month price target is $138.0625, suggesting that the stock has a possible upside of 66.10%. The high price target for ALNY is $230.00 and the low price target for ALNY is $63.00. There are currently 1 sell rating, 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.782.70
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $138.0625$138.5625$146.5882$141.15
Price Target Upside: 66.10% upside86.49% upside80.39% upside32.82% upside

Alnylam Pharmaceuticals (NASDAQ:ALNY) Consensus Price Target History

Price Target History for Alnylam Pharmaceuticals (NASDAQ:ALNY)

Alnylam Pharmaceuticals (NASDAQ:ALNY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/15/2019Piper Jaffray CompaniesLower Price TargetOverweight$152.00LowView Rating Details
12/17/2018GuggenheimInitiated CoverageBuy$105.00MediumView Rating Details
12/7/2018Cantor FitzgeraldReiterated RatingBuy$135.00HighView Rating Details
11/27/2018Leerink SwannInitiated CoverageMarket Perform$63.00LowView Rating Details
10/18/2018BMO Capital MarketsReiterated RatingBuyHighView Rating Details
9/28/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$93.00 ➝ $87.00HighView Rating Details
9/13/2018Needham & Company LLCReiterated RatingBuy$152.00MediumView Rating Details
9/13/2018Stifel NicolausReiterated RatingBuy$123.00 ➝ $117.00MediumView Rating Details
9/4/2018CowenReiterated RatingBuy$147.00HighView Rating Details
8/28/2018JMP SecuritiesSet Price TargetBuy$198.00MediumView Rating Details
8/13/2018B. RileyBoost Price TargetBuy ➝ Buy$210.00 ➝ $230.00HighView Rating Details
8/13/2018NomuraLower Price TargetReduce ➝ Reduce$86.00 ➝ $73.00HighView Rating Details
8/13/2018Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyLowView Rating Details
8/6/2018Jefferies Financial GroupReiterated RatingBuy$149.00LowView Rating Details
8/3/2018Chardan CapitalReiterated RatingBuy$180.00HighView Rating Details
3/28/2018Evercore ISIInitiated CoverageIn ➝ line$131.18 ➝ $143.00MediumView Rating Details
3/13/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$151.00 ➝ $154.00HighView Rating Details
11/9/2017JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightN/AView Rating Details
11/8/2017BarclaysBoost Price TargetOverweight$127.00 ➝ $158.00N/AView Rating Details
10/30/2017FBR & CoInitiated CoverageBuy ➝ Buy$150.00N/AView Rating Details
9/21/2017LADENBURG THALM/SH SHReiterated RatingBuy$90.00 ➝ $146.00LowView Rating Details
9/21/2017Sanford C. BernsteinReiterated RatingOutperform ➝ Buy$94.00 ➝ $135.00LowView Rating Details
9/15/2017InstinetInitiated CoverageReduce ➝ Reduce$56.00LowView Rating Details
6/2/2017Janney Montgomery ScottInitiated CoverageUnderperform ➝ Sell$69.70 ➝ $67.00LowView Rating Details
3/29/2017UBS GroupInitiated CoverageNeutral ➝ Neutral$55.00N/AView Rating Details
(Data available from 1/22/2017 forward)
This page was last updated on 1/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel